Concord Medical Services Holdings Limited (CCM)
- Simply Wall St.
Concord Medical Services Holdings Full Year 2023 Earnings: CN¥6.81 loss per share (vs CN¥11.21 loss in FY 2022)
Concord Medical Services Holdings ( NYSE:CCM ) Full Year 2023 Results Key Financial Results Revenue: CN¥537.4m (up 14...
- PR Newswire
Concord Medical Files 2023 Annual Report on Form 20-F
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on
- PR Newswire
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure perio
